Shukra Pharmaceuticals Limited
Filed with BSE · · 2 pages · English
Shukra Pharmaceuticals Ltd. on 6ix
Earlier from Shukra Pharmaceuticals
- Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended September 2026
- Announcement under Regulation 30 (LODR)-Change of Company Name
- Board Meeting Outcome for Allotment Of Shares Pursuant To Conversion Of Warrants
- Clarification From The Company
- Shukra Pharmaceuticals Ltd. Press Release Sep 29 2026
Follow Shukra Pharmaceuticals into a list and get an email when it puts out news.
Follow Shukra Pharmaceuticals